video
Trilostane 13647-35-3

Trilostane 13647-35-3

CAS Number: 13647-35-3
Standard: In-house standard
Trilostane API, with the chemical compound identified by the CAS number 13647-35-3, is primarily used in veterinary medicine for the treatment of Cushing's syndrome in dogs.

Product Introduction

Trilostane

Effective Management of Canine Cushing's Syndrome

Trilostane is a well-established active pharmaceutical ingredient (API) widely used in veterinary medicine for the treatment of Cushing's syndrome (hyperadrenocorticism) in dogs. By targeting excessive cortisol production, Trilostane plays a vital role in improving clinical outcomes and enhancing the quality of life of affected animals.

Cushing's Syndrome in Dogs

Cushing's syndrome is a chronic endocrine disorder caused by the overproduction of cortisol by the adrenal glands. Dogs suffering from this condition often exhibit symptoms such as:

Excessive thirst and frequent urination

Weight gain and abdominal distension ("pot-bellied" appearance)

Hair loss and poor coat condition

Muscle weakness and lethargy

If left untreated, prolonged high cortisol levels can lead to serious health complications. Trilostane offers an effective therapeutic solution by addressing the root cause of the disorder.

Mechanism of Action

Trilostane acts as a synthetic steroid analogue that selectively inhibits the enzyme 3-beta-hydroxysteroid dehydrogenase (3β-HSD). This enzyme is essential in the biosynthesis of cortisol. By blocking its activity, Trilostane reduces cortisol production in the adrenal glands, helping to control hormone imbalance and alleviate clinical symptoms.

Restoring Normal Cortisol Levels

The primary goal of Trilostane therapy is to normalize cortisol levels in dogs diagnosed with Cushing's syndrome. By effectively lowering excess cortisol, Trilostane helps:

Reduce excessive thirst and urination

Improve muscle strength and energy levels

Promote healthier skin and coat

Enhance overall well-being and longevity

Our Core Strengths

1. Integrated Production Ecosystem

Our advanced manufacturing facility spans 2,523 square meters and operates in full compliance with GMP (Good Manufacturing Practice) standards. Equipped with modern machinery and innovative technologies, we ensure stable production capacity, consistent quality, and reliable supply to meet global market demands.

2. Uncompromising Quality Assurance

Quality is embedded in every step of our production process. From carefully selected raw materials to final product delivery, each stage is subject to rigorous quality control. Strict environmental and process controls guarantee high purity, consistency, and efficacy of Trilostane API.

3.Customer-Centric Excellence

At Xiamen Origin, we are committed to building long-term partnerships through exceptional service. Our experienced team provides comprehensive technical support, regulatory assistance, and customized solutions tailored to customer needs. We strive to deliver dependable, efficient, and responsive support at every stage of collaboration.

Concerning Origin Biotech

Origin Biotech is committed to providing premium bioactive components and technological insights with scientific validation for use in pharmaceutical, nutraceutical, and research applications. Our platform supports professionals with trustworthy, high-quality APIs like Trilostane for veterinary medicine.

Interested in Trilostane API for Your Formulation?

We are able to offer:

Technical Documentation
Regulatory Assistance
Formulation Guidance
Bulk Supply Options

Get in touch with our team to find out how Trilostane API can support your next veterinary product development pipeline.

Hot Tags: trilostane 13647-35-3, China trilostane 13647-35-3 manufacturers, suppliers, factory, Maropitant Citrate, 356068-94-5, Denaverine Hydrochloride, 790299-79-5, Trilostane, 138261-41-3

Send Inquiry

whatsapp

Phone

VK

Inquiry

Bag